Will better evidence on clinical utility bring about greater use of (genetic) tests?
Greater clarity on the nature of clinical utility is desirable. Of itself it may not bring about greater use of tests, including WGS (whole-genome sequencing), not least because clinical utility studies when performed may not confirm predicted changes in patient outcome. The notion that single “pivo...
Guardado en:
Autor principal: | Chris Hyde |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c587ebd40d084605972d3dbf4b4dc870 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The impact of age on genetic risk for common diseases.
por: Xilin Jiang, et al.
Publicado: (2021) -
Clinical utility of genomic sequencing: a measurement toolkit
por: Robin Z. Hayeems, et al.
Publicado: (2020) -
Causal inference for heritable phenotypic risk factors using heterogeneous genetic instruments.
por: Jingshu Wang, et al.
Publicado: (2021) -
Multi-scale inference of genetic trait architecture using biologically annotated neural networks.
por: Pinar Demetci, et al.
Publicado: (2021) -
Gene-based tests of association.
por: Hailiang Huang, et al.
Publicado: (2011)